Cargando…
The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes
The energy metabolism of tumor cells relies on aerobic glycolysis rather than mitochondrial oxidation. This difference between normal and cancer cells provides a biochemical basis for new therapeutic strategies aimed to block the energy power plants of cells. The effects produced by the energy block...
Autores principales: | Davidescu, Magdalena, Macchioni, Lara, Scaramozzino, Gaetano, Cristina Marchetti, Maria, Migliorati, Graziella, Vitale, Rita, Corcelli, Angela, Roberti, Rita, Castigli, Emilia, Corazzi, Lanfranco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585687/ https://www.ncbi.nlm.nih.gov/pubmed/26387611 http://dx.doi.org/10.1038/srep14343 |
Ejemplares similares
-
The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells
por: Petricciuolo, Maya, et al.
Publicado: (2020) -
Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways
por: Macchioni, Lara, et al.
Publicado: (2017) -
The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate
por: Marrache, Sean, et al.
Publicado: (2015) -
Ru(III) Complexes with Lonidamine-Modified Ligands
por: Shutkov, Ilya A., et al.
Publicado: (2021) -
Phase II study of lonidamine in metastatic breast cancer.
por: Pronzato, P., et al.
Publicado: (1989)